Deep Sleep: How to Cure Insomnia & Live Longer | Stanford MD

Are you struggling with chronic insomnia and desperate for a solution that actually works? Do you lie awake at night, plagued by racing thoughts, only to…

Published January 27, 2025The Longevity Show

Insomnia gets treated as an inconvenience, and the mortality data says otherwise. Dr. Lin opens with the numbers: meta-analyses putting heart disease risk roughly 45% higher in people with insomnia, a long-running cohort in which insomniacs had more than three times the risk of death over 13 to 15 years — with the effect larger in men, even though insomnia is more common in women — and a 39% increase in mortality risk in older adults reporting trouble falling asleep or waking unrested. Rates of insomnia disorder run 6–10% of US adults, with global estimates spanning 2.3% to 25.5% depending entirely on how you define it.

The episode is built as a tiered toolkit rather than a list of tips, and the tiers are ordered by evidence and by durability. Sleep hygiene and circadian anchoring first. Then CBT-I, which the American College of Physicians recommends as first-line and which Dr. Lin frequently uses on its own — her reasoning being that behavioural change lasts and does not leave a patient dependent on a nightly pill. Then supplements with specific doses and mechanisms. Then prescription medication matched to symptom pattern rather than prescribed generically. Then the experimental tier — rTMS, light therapy, closed-loop auditory stimulation, temperature-controlled systems, taVNS.

Dr. Lin puts herself in the frame throughout, which is what makes the practical advice land. She is highly stress-reactive, comes from a maternal line where every member she can name has insomnia and runs anxious, lives in a Manhattan high-rise opposite a building that never turns its lights off, and has glued blockers to her window sill, wears earplugs and runs a loud air purifier as a white noise machine, keeps her phone out of the bedroom entirely, and does not read in bed. Note the scope: this instalment is about insomnia. It closes by flagging that many sleep problems only look like insomnia and need a different approach, which is the next episode.

Before you watch

Insomnia is three distinct problems and they respond to different things. Sleep onset insomnia is trouble falling asleep; sleep maintenance is repeated waking; early morning awakening is waking too early unable to return. Chronic insomnia is defined at three months or longer, versus acute insomnia triggered by a discrete stressor. It runs higher in women, older adults, and people with depression or anxiety — and over half of people reported sleep difficulties during the COVID-19 pandemic.
The mental health relationship runs both directions and Dr. Lin is emphatic about sequencing. People with insomnia are more than three times as likely to develop anxiety or depression — and if you are currently dealing with significant stress, anxiety or depression, her position is to address that first, because solving the sleep problem while the driver is untreated is extremely difficult.
Sleep is doing specific work, not just resting. Memory consolidation moves the day's short-term traces into long-term storage; the brain clears accumulated toxins; immune cell production and function increase, which is why people who sleep poorly are markedly more likely to catch a cold after viral exposure; growth hormone is released during deep sleep while cortisol falls; and REM processes emotional experience — Dr. Lin's framing is that REM functions like an overnight therapist, with the recurring nightmares of PTSD representing an emotional discharge the brain keeps attempting and failing to complete.
The appetite mechanism explains a common clinical dead end. Poor sleep raises ghrelin, the hunger hormone, and lowers leptin, the satiety hormone. Dr. Lin describes a retired executive who could not manage his weight despite eating well and training, and for whom sleep turned out to be the missing variable — once it was fixed, cravings dropped and late-night snacking became easy to cut.
Morning light is the single highest-leverage circadian intervention: 15 to 30 minutes outdoors shortly after waking resets the internal clock and makes melatonin production easier that night. Dr. Lin's realistic version for cold climates is that you do not need to dress properly or go far — walk around the block in your pyjamas, and the chill itself helps wake you.
Melatonin supplements are dosed far above physiological levels. Prolonged-release 2mg is often recommended for older adults, but Dr. Lin notes the body works with a few hundred micrograms to fall asleep — so she starts patients far lower, cutting 1mg gummies into halves or quarters. Because tolerance develops, she reserves melatonin largely for deliberately shifting a sleep-wake cycle, as in jet lag or shift work, rather than as an ongoing sleep aid.
The supplement tier is organised by what it targets, with specific doses attached: valerian root at 300–600mg raising GABA, sometimes combined with hops; L-theanine at 200mg boosting alpha brain waves for calm without sedation; GABA itself at 111.1mg; chamomile at 1–2g of dried flower; L-tryptophan at 1–2g and 5-HTP at 100–300mg for people whose insomnia tracks with low serotonin, low mood or anxiety; magnesium glycinate at 200–400mg; ashwagandha at 300mg extract twice daily for stress-driven insomnia; and passionflower at 500mg. Her protocol is one at a time, lowest dose, at least a week, and deliberate drug holidays to avoid dependence.
Dr. Lin does not like Z-drugs and says so. Zolpidem, eszopiclone and zaleplon work through the benzodiazepine pathway and carry sleep-driving and sleep-eating parasomnias, amnesia, coordination problems, daytime cognitive effects, tolerance and rebound insomnia on discontinuation. Her more fundamental objection is that they damage sleep architecture — you are unconscious without moving through the restorative cycles — and her stated concern about long-term use of this drug class includes cognitive effects and dementia risk. She almost never prescribes them.
The dual orexin receptor antagonists are the class she is genuinely enthusiastic about. Suvorexant, lemborexant and daridorexant block orexin, the neuropeptide that drives wakefulness — turning off the stay-awake signal rather than sedating the brain. Lower dependence risk, fewer next-day effects, no morning grogginess, and effective for both falling asleep and staying asleep. The catch is entirely economic: they are new, on patent, expensive, and frequently not covered by insurance.
Medication choice should follow the symptom pattern, not the drug's popularity. DORAs for people who struggle with both onset and maintenance and want to avoid dependence. Low-dose doxepin — single-digit milligram doses, where it acts as an antihistamine at the H1 receptor rather than as an antidepressant — for people who fall asleep fine but cannot stay asleep. Ramelteon at 8mg for circadian-driven insomnia. Off-label options include trazodone at 50–150mg, mirtazapine at 7.5–15mg where lower doses paradoxically work better for sleep than higher ones, and amitriptyline at 10–20mg. Quetiapine at 25–100mg is widely used, largely because hospitals use it, and Dr. Lin considers it a poor long-term choice given its side effects.
Alcohol and cannabis both feel like sleep aids and both damage REM. Alcohol induces drowsiness then fragments the sleep cycle — Dr. Lin notes the tension with the Mediterranean pattern she otherwise recommends, and suggests using a wearable to find your own cutoff time the same way you would with caffeine. Cannabis suppresses REM and creates dependence, so stopping produces its own insomnia. Neither is a preferred option in her framing.

Chapters

00:34

Advanced Sleep Therapies and Experimental Interventions for Insomnia

Questions

How much does insomnia actually shorten your life?

The associations Dr. Lin cites are substantial. Meta-analyses put the risk of developing heart disease around 45% higher in people with insomnia, and one long-running cohort found more than three times the risk of death over 13 to 15 years of follow-up — with the effect larger in men despite insomnia being more common in women. Separate research on older adults reporting difficulty falling asleep or waking unrested found a 39% increase in mortality risk. Beyond mortality, insomnia raises risk for coronary artery disease, heart attack, stroke, obesity, hypertension and type 2 diabetes, and more than triples the likelihood of developing anxiety or depression. These are observational associations, but the consistency across outcomes is why Dr. Lin treats sleep as a longevity intervention rather than a comfort issue.

What is CBT-I and does it work better than sleep medication?

Cognitive behavioural therapy for insomnia is the first-line treatment recommended by the American College of Physicians, and Dr. Lin frequently uses it on its own. It has five parts: sleep restriction, which deliberately limits time in bed so that bed stops being the place you lie awake, then extends as sleep efficiency improves; stimulus control, which reserves the bed for sleep and nothing else; cognitive therapy to challenge catastrophic beliefs about sleep; relaxation techniques; and sleep hygiene education. Her argument for preferring it is durability — it lasts, it improves baseline stress rather than only sleep, and it does not leave you dependent on a nightly supplement or prescription. She describes a patient who had cycled through multiple drugs and supplements without success and saw real improvement within a couple of months on CBT-I plus mindfulness. You can access it through a trained therapist or apps like Sleepio and CBT-i Coach.

What temperature should my bedroom be for good sleep?

Between 20 and 25°C, or 68 to 77°F — which Dr. Lin points out is warmer than the 65°F figure that circulates widely. In practice most people land in the high 60s to low 70s Fahrenheit, and she suggests experimenting rather than fixing on a number, since preference varies and how tightly your HVAC tracks the thermostat matters. Beyond temperature, the environment fixes that made the biggest difference in her own high-rise apartment were blackout measures — including blockers glued along the window sill to kill the light leaking in around the blinds — plus earplugs and a white noise source, in her case a deliberately loud air purifier.

Which sleep supplements actually have evidence behind them?

The episode groups them by target. For falling asleep: melatonin, though Dr. Lin notes supplement doses vastly exceed the few hundred micrograms the body actually uses and reserves it mainly for circadian shifts like jet lag or shift work; valerian root at 300–600mg, which raises GABA; and L-theanine at 200mg, which boosts alpha brain waves for calm without sedation. For staying asleep: GABA at 111.1mg, chamomile at 1–2g of dried flower, and L-tryptophan or 5-HTP where insomnia tracks with low serotonin, low mood or anxiety. For general stress reduction: magnesium glycinate at 200–400mg, ashwagandha at 300mg twice daily, and passionflower at 500mg. Her method matters as much as the list — one supplement at a time, lowest effective dose, at least a week before judging, deliberate off-days to prevent tolerance, and a conversation with your physician first if you take other medications.

Are prescription sleeping pills safe?

It depends heavily on the class. Dr. Lin is openly negative on Z-drugs — zolpidem, eszopiclone, zaleplon — because they work through the benzodiazepine pathway and carry parasomnias including sleep-driving and sleep-eating, amnesia, coordination problems, tolerance, dependence and rebound insomnia when stopped, and because they degrade sleep architecture: you are unconscious without getting restorative cycles. She says she almost never prescribes them. She is much more positive on the dual orexin receptor antagonists — suvorexant, lemborexant, daridorexant — which block the brain's wakefulness signal rather than sedating it, carry lower dependence risk and produce less next-day grogginess. Their real barrier is cost and insurance coverage while they remain on patent. Ramelteon is a low-risk option for circadian-driven insomnia, and low-dose doxepin suits people who fall asleep fine but cannot stay asleep. For older adults she notes controlled-release melatonin and low-dose doxepin are generally preferred over the benzodiazepine-pathway drugs.

Does alcohol or cannabis help you sleep?

Both make you feel sleepy and both make sleep worse. Alcohol disrupts the sleep cycle, particularly REM, producing more fragmented rest — Dr. Lin flags this as a genuine tension with the Mediterranean dietary pattern she otherwise recommends for sleep, and suggests treating alcohol like caffeine: use a wearable or sleep tracking to find how many hours before bed it stops affecting you, since that threshold is individual. Cannabis suppresses REM sleep, so the rest you get is less restorative, and regular use creates dependence such that stopping produces its own insomnia. Neither is a preferred option in her framing, though she acknowledges cannabis can serve in a short-term bind where it's legal.

The Longevity Letter